Xanthinal nicotinate combines the properties of drugs of the theophylline and nicotinic acid group: it has antiaggregant effect, expands peripheral vessels, improves collateral circulation.Blocking adenosine receptors and phosphodiesterase, increases the content of cyclic adenosine monophosphate in the cell, substrate stimulates the synthesis of NAD and NAD-phosphate. It improves microcirculation, oxygenation and nutrition of tissues, with prolonged use has antiatherosclerotic effect, activates the processes of fibrinolysis, lowers the concentration of cholesterol and atherogenic lipids, increases lipoprotein lipase activity, reduces blood viscosity, reduces platelet aggregation.
Reducing the general ceriferous vascular resistance and strengthening myocardial contractions, contributes to an increase in the minute volume of blood and increased cerebral circulation, reduces the severity of the consequences of cerebral hypoxia.
Xanthinal nicotinate causes a "nicotine-like" syndrome, accompanied by hyperesthesia of the mucous membrane of the nasal cavity and mouth: exacerbates the sensitivity of olfactory and taste sensations. In this regard, the smell and taste of the alcoholic beverages offered during the "nicotine-like" reaction is perceived to be more harsh and unpleasant.